Genomic health, inc (GHDX)
Income statement / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Total revenues

114,355

114,140

108,769

104,609

101,258

95,619

92,625

87,463

83,821

85,487

83,979

-

82,258

81,974

-

-

-

73,554

-

-

-

-

-

68,820

65,990

63,691

63,094

60,427

58,648

57,631

58,467

53,397

52,058

50,846

49,810

46,317

43,439

Operating expenses:
Cost of product revenues

18,709

17,674

17,008

15,692

15,518

14,383

18,733

13,815

13,433

13,798

13,672

13,652

13,425

15,598

16,153

14,937

13,718

13,718

12,762

12,501

11,979

12,207

12,055

10,816

10,781

10,757

9,746

9,642

9,037

9,013

9,326

7,352

9,195

8,226

9,059

8,853

8,107

Research and development

16,457

15,318

15,054

16,648

15,433

15,312

16,807

14,944

17,212

15,781

14,874

14,854

14,746

14,948

15,610

12,367

13,480

13,480

19,118

12,550

13,891

12,630

14,005

21,988

14,726

13,800

13,663

13,329

12,267

11,579

11,929

10,283

9,611

9,879

10,091

8,180

7,980

Selling and marketing

39,910

44,639

45,348

42,636

40,051

40,337

41,755

36,535

38,303

40,656

41,507

34,715

38,838

37,989

39,500

37,467

35,369

35,369

35,352

35,143

34,059

35,236

33,408

31,171

26,013

28,135

27,439

23,896

21,526

23,765

24,366

22,391

20,157

20,529

20,536

17,336

17,517

General and administrative

20,233

21,011

19,820

20,207

18,498

18,487

19,718

20,019

17,505

18,395

16,751

18,029

18,268

18,537

18,438

15,909

16,425

16,425

15,589

14,919

15,007

15,015

14,728

13,340

14,007

13,910

13,135

11,546

12,107

11,436

11,975

10,639

9,696

9,852

10,356

8,561

8,752

Total operating expenses

95,309

98,642

97,230

95,183

89,500

88,519

97,013

85,313

86,453

88,630

86,804

81,250

85,277

87,072

89,701

80,680

78,992

78,992

82,821

75,113

74,936

75,088

74,196

77,315

65,527

66,602

63,983

58,413

54,937

55,793

57,596

50,665

48,659

48,486

50,042

42,930

42,356

Income from operations

19,046

15,498

11,539

9,426

11,758

7,100

-4,388

2,150

-2,632

-3,143

-2,825

1,492

-3,019

-5,098

-8,807

-8,482

-5,438

-5,438

-14,669

-5,987

-5,835

-4,611

-7,194

-8,495

463

-2,911

-889

2,014

3,711

1,838

871

2,732

3,399

2,360

-232

3,387

1,083

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

54

-

-

48

47

47

50

48

52

57

65

70

77

74

74

4

77

75

65

55

-

Interest income

1,389

1,334

1,151

892

676

400

417

307

263

206

158

136

117

87

78

58

55

54

54

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

54

Unrealized (loss) gain on equity securities

-1,239

-301

449

-662

127

1,283

127

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of equity securities

-

-

-

-

-

-

-

0

0

0

2,807

1,199

0

676

1,333

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other (expense) income, net

-296

-204

127

-332

39

-248

309

-443

340

357

95

-558

-111

-150

87

192

-158

-158

-374

-227

-345

34

-226

-156

89

-85

-6

54

33

-73

-72

-14

-113

-28

-50

13

-21

Income before income taxes

18,900

16,327

13,266

9,324

12,600

8,535

-3,535

2,021

-2,029

-2,580

235

2,269

-3,013

-4,485

-7,309

-8,231

-5,542

-5,542

-14,989

-6,166

-6,133

-4,530

-7,370

-9,246

604

-2,939

-830

2,138

3,821

1,839

873

2,722

3,363

2,407

-217

3,455

1,116

Income tax expense

206

340

267

414

375

218

240

142

162

159

1,041

917

-193

1,615

-958

-8,102

6,301

6,301

-5,496

101

129

88

75

122

116

55

53

179

109

38

96

163

138

59

69

-215

251

Net income

18,694

15,987

12,999

8,910

12,225

8,317

-3,775

1,879

-2,191

-2,739

-806

1,352

-2,820

-6,100

-6,351

-129

-11,843

-11,843

-9,493

-6,267

-6,262

-4,618

-7,445

-9,368

488

-2,994

-883

1,959

3,712

1,801

777

2,559

3,225

2,348

-286

3,670

865

Basic and diluted net loss per share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-0.02

-

-0.08

-0.18

-0.19

-0.01

-0.36

-0.36

-0.30

-0.19

-0.20

-0.15

-0.24

-

-

-0.10

-0.03

-

-

-

-

-

-

-

-

-

-

Shares used in computing basic and diluted net loss per share (in shares)

-

-

-

-

-

-

-

-

-

-

34,009

-

33,391

33,130

32,900

32,477

32,498

32,498

32,055

31,802

31,590

31,333

31,087

-

-

30,464

30,099

-

-

-

-

-

-

-

-

-

-

Basic net income per share (in dollars per share)

0.50

0.43

0.35

0.26

0.34

0.23

-0.11

-

-0.06

-0.08

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.02

-

-

0.06

0.12

0.06

0.03

0.09

0.11

0.08

-0.01

0.13

0.03

Diluted net income per share (in dollars per share)

0.48

0.42

0.34

0.24

0.32

0.23

-0.11

-

-0.06

-0.08

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.02

-

-

0.07

0.11

0.06

0.02

0.09

0.10

0.08

-0.01

0.12

0.03

Shares used in computing basic net income per share (in shares)

37,411

37,126

36,719

36,241

35,925

35,544

35,198

-

34,675

34,428

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30,661

-

-

30,610

30,580

30,204

29,910

29,653

29,491

29,332

29,104

28,832

28,794

Shares used in computing diluted net income per share (in shares)

38,958

38,507

38,764

40,280

38,026

36,716

35,198

-

34,675

34,428

-

-

-

-

-

-

-

-

-

-

-

-

-

-

32,324

-

-

32,357

32,578

32,064

31,609

32,234

30,808

30,870

29,104

29,584

29,627

Product
Total revenues

114,355

114,140

108,757

104,609

101,258

95,619

92,625

-

-

-

-

82,002

82,136

81,886

80,894

72,198

73,554

73,554

68,152

69,126

69,101

70,477

67,002

67,060

65,732

63,691

62,709

59,997

58,371

57,185

57,904

53,154

51,661

50,493

49,458

45,773

42,514

Contract
Total revenues

0

0

12

-

-

-

-

-

-

-

-

-

122

88

-

-

-

-

-

-

-

-

-

1,760

258

0

385

430

277

446

563

243

397

353

352

544

925